Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systolic Hypertension in the Elderly Program (SHEP)
NCT00000514Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 1984
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of chlorthalidone, atenolol, reserpine in isolated systolic hypertension (ISH), sponsored by National Heart, Lung, and Blood Institute. Started Jun 1984; status: completed.
02
Drugs
chlorthalidoneatenololreserpine
03
Conditions
isolated systolic hypertension (ISH)
Beyond the preview
Go deeper on NCT00000514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000514.